Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent Garima20 March 2019 9:46 AM ISTAs part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...